Fund: FTBDF
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912 | |
LU0109394709 | |
03-04-2000 | |
Equity | |
Equity Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
USD | |
1,000 | |
5.75% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 2.79% | 11.78% | 8.39% | 28.31% | 37.00% | 2.29% | 8.66% | 4.71% | 4.80% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.31% | -0.86% | -0.03% | 3.05% | 2.42% | ||||||
Volatilita od priemernej výkonnosti | 9.27% | 32.89% | 7.60% | 5.55% | 4.23% |
Long | Short | Net | |
---|---|---|---|
Stock | 98.56% | 98.56% | |
Bond | |||
Other | 0.68% | 0.68% | |
Cash | 1.39% | 0.63% | 0.76% |
Aktíva | 12,416 mil. |
Počet akcíí | 84 |
Počet dlhopisov | 1 |
Priebež. popl. | 1.81 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.04 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 2.85% |
Large | 25.79% |
Medium | 20.26% |
Small | 15.41% |
Micro | 27.26% |
P/E | 18.74% |
P/BV | 3.74% |
Basic Materials | 1.08% |
Healthcare | 95.40% |
Corporate | 0.68 |
Derivatives | 0.76 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 0.00 |
AA | 67.14 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 32.86 |
United States | 84.44% |
Canada | 0.73% |
Latin America | |
United Kingdom | 3.30% |
Eurozone | 4.48% |
Europe - ex Euro | 4.62% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 97.58% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 8.19% | Regeneron Pharmaceuticals Inc | Healthcare | 7.14% |
Vertex Pharmaceuticals Inc | Healthcare | 6.04% | Insmed Inc | Healthcare | 3.76% |
Ascendis Pharma A/S ADR | Healthcare | 3.62% | Gilead Sciences Inc | Healthcare | 3.27% |
Intra-Cellular Therapies Inc | Healthcare | 2.97% | Biogen Inc | Healthcare | 2.93% |
AstraZeneca PLC ADR | Healthcare | 2.85% | Merus NV | Healthcare | 2.82% |